Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection
Abstract Background Helicobacter pylori (H. pylori) causes chronic gastric disease. An efficient oral vaccine would be mucosa-targeted and offer defense against colonization of invasive infection in the digestive system. Proteolytic enzymes and acidic environment in the gastrointestinal tract (GT) c...
Main Authors: | Furui Zhang, Linhan Ni, Zhen Zhang, Xuegang Luo, Xuequan Wang, Wenmiao Zhou, Jiale Chen, Jing Liu, Yuliang Qu, Kunmei Liu, Le Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-02-01
|
Series: | Microbial Cell Factories |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12934-024-02321-4 |
Similar Items
-
Oral Immunization With a M Cell-Targeting Recombinant L. Lactis Vaccine LL-plSAM-FVpE Stimulate Protective Immunity Against H. Pylori in Mice
by: Le Guo, et al.
Published: (2022-07-01) -
Mechanisms of interacting <i>Helicobacter pylori</i> with gastric mucosal epithelium. II. A reaction of gastric epithelium on <i>Helicobacter pylori</i> colonization and persistence
by: O. K. Pozdeev, et al.
Published: (2019-07-01) -
How Does Helicobacter pylori Infection Cause Gastric Mucosal Atrophy
by: Wang YK, et al.
Published: (2022-07-01) -
M cells targeted H. pylori antigen SAM-FAdE displayed on bacterium-like particles induce protective immunity
by: Furui Zhang, et al.
Published: (2025-01-01) -
Vaccine Strategies to Elicit Mucosal Immunity
by: Yufeng Song, et al.
Published: (2024-02-01)